PubMed@dpavot:32491073_en_relations
Annnotations
ENG_RE
{"project":"ENG_RE","denotations":[{"id":"T0","span":{"begin":12,"end":19},"obj":"DOID_4"},{"id":"T1","span":{"begin":26,"end":34},"obj":"DOID_0080600"},{"id":"T2","span":{"begin":116,"end":124},"obj":"DOID_0080600"},{"id":"T3","span":{"begin":241,"end":249},"obj":"DOID_0080600"},{"id":"T4","span":{"begin":283,"end":294},"obj":"HP_0012819"},{"id":"T5","span":{"begin":283,"end":294},"obj":"DOID_820"},{"id":"T6","span":{"begin":377,"end":391},"obj":"CHEBI_35457"},{"id":"T7","span":{"begin":381,"end":391},"obj":"CHEBI_35222"},{"id":"T8","span":{"begin":396,"end":407},"obj":"CHEBI_2719"},{"id":"T9","span":{"begin":450,"end":462},"obj":"HP_0000822"},{"id":"T10","span":{"begin":450,"end":462},"obj":"DOID_10763"},{"id":"T11","span":{"begin":467,"end":480},"obj":"HP_0001635"},{"id":"T12","span":{"begin":484,"end":492},"obj":"DOID_0080600"},{"id":"T13","span":{"begin":562,"end":570},"obj":"DOID_0080600"}],"relations":[{"id":"R13","pred":"no_relation","subj":"T12","obj":"T8"},{"id":"R14","pred":"no_relation","subj":"T13","obj":"T6"},{"id":"R15","pred":"no_relation","subj":"T13","obj":"T8"},{"id":"R0","pred":"effect","subj":"T0","obj":"T6"},{"id":"R1","pred":"effect","subj":"T0","obj":"T8"},{"id":"R2","pred":"effect","subj":"T1","obj":"T6"},{"id":"R3","pred":"effect","subj":"T1","obj":"T8"},{"id":"R4","pred":"effect","subj":"T2","obj":"T6"},{"id":"R5","pred":"effect","subj":"T2","obj":"T8"},{"id":"R6","pred":"effect","subj":"T3","obj":"T6"},{"id":"R7","pred":"effect","subj":"T3","obj":"T8"},{"id":"R8","pred":"effect","subj":"T5","obj":"T6"},{"id":"R9","pred":"effect","subj":"T5","obj":"T8"},{"id":"R10","pred":"no_relation","subj":"T10","obj":"T6"},{"id":"R11","pred":"no_relation","subj":"T10","obj":"T8"},{"id":"R12","pred":"no_relation","subj":"T12","obj":"T6"}],"text":"Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19."}
ENG_RE_Diana
{"project":"ENG_RE_Diana","denotations":[{"id":"T0","span":{"begin":12,"end":19},"obj":"DOID_4"},{"id":"T1","span":{"begin":26,"end":34},"obj":"DOID_0080600"},{"id":"T10","span":{"begin":450,"end":462},"obj":"DOID_10763"},{"id":"T11","span":{"begin":467,"end":480},"obj":"HP_0001635"},{"id":"T12","span":{"begin":484,"end":492},"obj":"DOID_0080600"},{"id":"T13","span":{"begin":562,"end":570},"obj":"DOID_0080600"},{"id":"T2","span":{"begin":116,"end":124},"obj":"DOID_0080600"},{"id":"T3","span":{"begin":241,"end":249},"obj":"DOID_0080600"},{"id":"T4","span":{"begin":283,"end":294},"obj":"HP_0012819"},{"id":"T5","span":{"begin":283,"end":294},"obj":"DOID_820"},{"id":"T6","span":{"begin":377,"end":391},"obj":"CHEBI_35457"},{"id":"T7","span":{"begin":381,"end":391},"obj":"CHEBI_35222"},{"id":"T8","span":{"begin":396,"end":407},"obj":"CHEBI_2719"},{"id":"T9","span":{"begin":450,"end":462},"obj":"HP_0000822"},{"id":"T14","span":{"begin":0,"end":24},"obj":"DOID_0080600"}],"relations":[{"id":"R0","pred":"effect","subj":"T0","obj":"T6"},{"id":"R1","pred":"effect","subj":"T0","obj":"T8"},{"id":"R10","pred":"effect","subj":"T10","obj":"T6"},{"id":"R11","pred":"effect","subj":"T10","obj":"T8"},{"id":"R12","pred":"effect","subj":"T12","obj":"T6"},{"id":"R13","pred":"effect","subj":"T12","obj":"T8"},{"id":"R14","pred":"effect","subj":"T13","obj":"T6"},{"id":"R15","pred":"effect","subj":"T13","obj":"T8"},{"id":"R2","pred":"effect","subj":"T1","obj":"T6"},{"id":"R3","pred":"effect","subj":"T1","obj":"T8"},{"id":"R4","pred":"effect","subj":"T2","obj":"T6"},{"id":"R5","pred":"effect","subj":"T2","obj":"T8"},{"id":"R6","pred":"effect","subj":"T3","obj":"T6"},{"id":"R7","pred":"effect","subj":"T3","obj":"T8"},{"id":"R8","pred":"effect","subj":"T5","obj":"T6"},{"id":"R9","pred":"effect","subj":"T5","obj":"T8"},{"id":"R16","pred":"effect","subj":"T4","obj":"T3"},{"id":"R17","pred":"effect","subj":"T5","obj":"T3"},{"id":"R18","pred":"effect","subj":"T11","obj":"T8"},{"id":"R19","pred":"effect","subj":"T11","obj":"T6"},{"id":"R20","pred":"effect","subj":"T9","obj":"T8"},{"id":"R21","pred":"effect","subj":"T9","obj":"T6"}],"text":"Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19."}
RELASIGEBLAH7hhaider5
{"project":"RELASIGEBLAH7hhaider5","denotations":[{"id":"T0","span":{"begin":12,"end":19},"obj":"DOID_4"},{"id":"T1","span":{"begin":26,"end":34},"obj":"DOID_0080600"},{"id":"T10","span":{"begin":450,"end":462},"obj":"DOID_10763"},{"id":"T11","span":{"begin":467,"end":480},"obj":"HP_0001635"},{"id":"T12","span":{"begin":484,"end":492},"obj":"DOID_0080600"},{"id":"T13","span":{"begin":562,"end":570},"obj":"DOID_0080600"},{"id":"T2","span":{"begin":116,"end":124},"obj":"DOID_0080600"},{"id":"T3","span":{"begin":241,"end":249},"obj":"DOID_0080600"},{"id":"T4","span":{"begin":283,"end":294},"obj":"HP_0012819"},{"id":"T5","span":{"begin":283,"end":294},"obj":"DOID_820"},{"id":"T6","span":{"begin":377,"end":391},"obj":"CHEBI_35457"},{"id":"T7","span":{"begin":381,"end":391},"obj":"CHEBI_35222"},{"id":"T8","span":{"begin":396,"end":407},"obj":"CHEBI_2719"},{"id":"T9","span":{"begin":450,"end":462},"obj":"HP_0000822"}],"relations":[{"id":"R0","pred":"effect","subj":"T0","obj":"T6"},{"id":"R1","pred":"effect","subj":"T0","obj":"T8"},{"id":"R10","pred":"no_relation","subj":"T10","obj":"T6"},{"id":"R11","pred":"effect","subj":"T10","obj":"T8"},{"id":"R12","pred":"effect","subj":"T12","obj":"T6"},{"id":"R13","pred":"effect","subj":"T12","obj":"T8"},{"id":"R14","pred":"no_relation","subj":"T13","obj":"T6"},{"id":"R15","pred":"effect","subj":"T13","obj":"T8"},{"id":"R2","pred":"effect","subj":"T1","obj":"T6"},{"id":"R3","pred":"effect","subj":"T1","obj":"T8"},{"id":"R4","pred":"effect","subj":"T2","obj":"T6"},{"id":"R5","pred":"effect","subj":"T2","obj":"T8"},{"id":"R6","pred":"effect","subj":"T3","obj":"T6"},{"id":"R7","pred":"effect","subj":"T3","obj":"T8"},{"id":"R8","pred":"effect","subj":"T5","obj":"T6"},{"id":"R9","pred":"effect","subj":"T5","obj":"T8"}],"text":"Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19."}
ENG_RE_pruas
{"project":"ENG_RE_pruas","denotations":[{"id":"T1","span":{"begin":26,"end":34},"obj":"DOID_0080600"},{"id":"T10","span":{"begin":450,"end":462},"obj":"DOID_10763"},{"id":"T11","span":{"begin":467,"end":480},"obj":"HP_0001635"},{"id":"T12","span":{"begin":484,"end":492},"obj":"DOID_0080600"},{"id":"T13","span":{"begin":562,"end":570},"obj":"DOID_0080600"},{"id":"T2","span":{"begin":116,"end":124},"obj":"DOID_0080600"},{"id":"T3","span":{"begin":241,"end":249},"obj":"DOID_0080600"},{"id":"T4","span":{"begin":283,"end":294},"obj":"HP_0012819"},{"id":"T5","span":{"begin":283,"end":294},"obj":"DOID_820"},{"id":"T9","span":{"begin":450,"end":462},"obj":"HP_0000822"},{"id":"T14","span":{"begin":0,"end":24},"obj":"DOID_0080600"},{"id":"T15","span":{"begin":191,"end":219},"obj":"HP_0001626"},{"id":"T16","span":{"begin":396,"end":425},"obj":"CHEBI_61016"},{"id":"T6","span":{"begin":377,"end":391},"obj":"CHEBI_35457"}],"relations":[{"id":"R10","pred":"negative","subj":"T10","obj":"T6"},{"id":"R11","pred":"negative","subj":"T10","obj":"T6"},{"id":"R12","pred":"negative","subj":"T16","obj":"T9"},{"id":"R13","pred":"negative","subj":"T16","obj":"T11"},{"id":"R14","pred":"negative","subj":"T6","obj":"T10"},{"id":"R15","pred":"negative","subj":"T6","obj":"T11"},{"id":"R16","pred":"effect","subj":"T15","obj":"T3"},{"id":"R17","pred":"effect","subj":"T5","obj":"T3"},{"id":"R18","pred":"effect","subj":"T5","obj":"T12"},{"id":"R19","pred":"effect","subj":"T15","obj":"T12"},{"id":"R20","pred":"effect","subj":"T15","obj":"T13"},{"id":"R21","pred":"effect","subj":"T15","obj":"T2"},{"id":"R22","pred":"effect","subj":"T15","obj":"T1"},{"id":"R23","pred":"effect","subj":"T15","obj":"T14"},{"id":"R24","pred":"effect","subj":"T5","obj":"T13"},{"id":"R25","pred":"effect","subj":"T5","obj":"T2"},{"id":"R26","pred":"effect","subj":"T5","obj":"T1"},{"id":"R27","pred":"effect","subj":"T5","obj":"T14"}],"text":"Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19."}
ENG_RE_mabarros
{"project":"ENG_RE_mabarros","denotations":[{"id":"T0","span":{"begin":12,"end":19},"obj":"DOID_4"},{"id":"T1","span":{"begin":26,"end":34},"obj":"DOID_0080600"},{"id":"T10","span":{"begin":450,"end":462},"obj":"DOID_10763"},{"id":"T11","span":{"begin":467,"end":480},"obj":"HP_0001635"},{"id":"T12","span":{"begin":484,"end":492},"obj":"DOID_0080600"},{"id":"T13","span":{"begin":562,"end":570},"obj":"DOID_0080600"},{"id":"T2","span":{"begin":116,"end":124},"obj":"DOID_0080600"},{"id":"T3","span":{"begin":241,"end":249},"obj":"DOID_0080600"},{"id":"T4","span":{"begin":283,"end":294},"obj":"HP_0012819"},{"id":"T5","span":{"begin":283,"end":294},"obj":"DOID_820"},{"id":"T6","span":{"begin":377,"end":391},"obj":"CHEBI_35457"},{"id":"T7","span":{"begin":381,"end":391},"obj":"CHEBI_35222"},{"id":"T8","span":{"begin":396,"end":407},"obj":"CHEBI_2719"},{"id":"T9","span":{"begin":450,"end":462},"obj":"HP_0000822"}],"relations":[{"id":"R0","pred":"effect","subj":"T0","obj":"T6"},{"id":"R1","pred":"effect","subj":"T0","obj":"T8"},{"id":"R10","pred":"no_relation","subj":"T10","obj":"T6"},{"id":"R11","pred":"no_relation","subj":"T10","obj":"T8"},{"id":"R12","pred":"no_relation","subj":"T12","obj":"T6"},{"id":"R13","pred":"no_relation","subj":"T12","obj":"T8"},{"id":"R14","pred":"no_relation","subj":"T13","obj":"T6"},{"id":"R15","pred":"no_relation","subj":"T13","obj":"T8"},{"id":"R2","pred":"effect","subj":"T1","obj":"T6"},{"id":"R3","pred":"effect","subj":"T1","obj":"T8"},{"id":"R4","pred":"effect","subj":"T2","obj":"T6"},{"id":"R5","pred":"effect","subj":"T2","obj":"T8"},{"id":"R6","pred":"effect","subj":"T3","obj":"T6"},{"id":"R7","pred":"effect","subj":"T3","obj":"T8"},{"id":"R8","pred":"effect","subj":"T5","obj":"T6"},{"id":"R9","pred":"effect","subj":"T5","obj":"T8"},{"id":"R16","pred":"effect","subj":"T3","obj":"T5"}],"text":"Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19."}